Cargando…

Dietary Pyridoxine Controls Efficacy of Vitamin B(6)-Auxotrophic Tuberculosis Vaccine Bacillus Calmette-Guérin ΔureC::hly Δpdx1 in Mice

The only tuberculosis (TB) vaccine in use today, bacillus Calmette-Guérin (BCG), provides insufficient protection and can cause adverse events in immunocompromised individuals, such as BCGosis in HIV(+) newborns. We previously reported improved preclinical efficacy and safety of the recombinant vacc...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gengenbacher, Martin, Vogelzang, Alexis, Schuerer, Stefanie, Lazar, Doris, Kaiser, Peggy, Kaufmann, Stefan H. E.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Society of Microbiology 2014
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4049106/ https://www.ncbi.nlm.nih.gov/pubmed/24895310 http://dx.doi.org/10.1128/mBio.01262-14

Ejemplares similares

The Tuberculosis Vaccine Candidate Bacillus Calmette-Guérin ΔureC::hly Coexpressing Human Interleukin-7 or -18 Enhances Antigen-Specific T Cell Responses in Mice
por: Rao, Martin, et al.
Publicado: (2013)

Deletion of nuoG from the Vaccine Candidate Mycobacterium bovis BCG ΔureC::hly Improves Protection against Tuberculosis
por: Gengenbacher, Martin, et al.
Publicado: (2016)

Central Memory CD4(+) T Cells Are Responsible for the Recombinant Bacillus Calmette-Guérin ΔureC::hly Vaccine's Superior Protection Against Tuberculosis
por: Vogelzang, Alexis, et al.
Publicado: (2014)

Recombinant BCG ΔureC hly+ Induces Superior Protection Over Parental BCG by Stimulating a Balanced Combination of Type 1 and Type 17 Cytokine Responses
por: Desel, Christiane, et al.
Publicado: (2011)

Archaeal amoA and ureC genes and their transcriptional activity in the Arctic Ocean
por: Pedneault, Estelle, et al.
Publicado: (2014)

Corrigendum: Archaeal amoA and ureC genes and their transcriptional activity in the Arctic Ocean
por: Pedneault, Estelle, et al.
Publicado: (2015)

Stable expression of Mycobacterium bovis antigen 85B in auxotrophic M. bovis bacillus Calmette-Guérin
por: Rizzi, Caroline, et al.
Publicado: (2017)

Differences in Ureolytic Bacterial Composition between the Rumen Digesta and Rumen Wall Based on ureC Gene Classification
por: Jin, Di, et al.
Publicado: (2017)

Phylogenetically Diverse ureC Genes and Their Expression Suggest the Urea Utilization by Bacterial Symbionts in Marine Sponge Xestospongia testudinaria
por: Su, Jing, et al.
Publicado: (2013)

Next-Generation Vaccines Based on Bacille Calmette–Guérin
por: Nieuwenhuizen, Natalie E., et al.
Publicado: (2018)

Comprehensive Characterization of the Attenuated Double Auxotroph Mycobacterium tuberculosisΔleuDΔpanCD as an Alternative to H37Rv
por: Mouton, Jomien M., et al.
Publicado: (2019)

Bacillus Calmette-Guerin (BCG) induces superior anti-tumour responses by Vδ2(+) T cells compared with the aminobisphosphonate drug zoledronic acid
por: Fenn, J, et al.
Publicado: (2022)

Construction and characterization of thymidine auxotrophic (ΔthyA) recombinant Lactobacillus casei expressing bovine lactoferricin
por: Zhou, Han, et al.
Publicado: (2018)

Bacille Calmette-Guérin: An ophthalmic perspective
por: Jain, Manish, et al.
Publicado: (2022)

Bacillus Calmette–Guérin Immunotherapy for Cancer
por: Cardillo, Fabíola, et al.
Publicado: (2021)

Are Bacille Calmette-Guérin Skin Reactions the Most Important Correlates of Bacille Calmette-Guérin’s Specific and Nonspecific Effects?
por: Schaltz-Buchholzer, Frederik
Publicado: (2022)

Pyridoxine biosynthesis protein MoPdx1 affects the development and pathogenicity of Magnaporthe oryzae
por: Yang, Lina, et al.
Publicado: (2023)

Nanocages engineered from Bacillus Calmette-Guerin facilitate protective Vγ2Vδ2 T cell immunity against Mycobacterium tuberculosis infection
por: Pi, Jiang, et al.
Publicado: (2022)

Frequency of hlyA, hlyB, hlyC and hlyD genes in uropathogenic Escherichia coli isolated from UTI patients in Shiraz
por: Moeinizadeh, Heliyaneh, et al.
Publicado: (2021)

VARIABILITY OF BCG STRAINS (BACILLUS CALMETTE-GUÉRIN)
por: Suter, W. Emanuel, et al.
Publicado: (1951)

Tuberculosis vaccines: beyond bacille Calmette–Guérin
por: McShane, Helen
Publicado: (2011)

Disseminated Bacillus Calmette-Guérin Infection and Immunodeficiency
por: Bernatowska, Ewa Anna, et al.
Publicado: (2007)

Bacillus Calmette-Guerin (BCG) vaccine in Iran
por: Fallah, Fatemeh, et al.
Publicado: (2018)

Bacillus Calmette-Guerin (BCG): the adroit vaccine
por: Adesanya, Oluwafolajimi A., et al.
Publicado: (2021)

Bacillus Calmette-Guerin Vaccine and Nonspecific Immunity
por: Parmar, Kanak, et al.
Publicado: (2021)

100 years of the Bacillus Calmette-Guérin vaccine
por: Bettencourt, Paulo J.G., et al.
Publicado: (2021)

Clinical Course of Bacillus Calmette-Guerin Lymphadenitis
por: Ko, Dayoung, et al.
Publicado: (2022)

Predictive biomarkers of response to bacillus Calmette‐Guérin immunotherapy and bacillus Calmette‐Guérin failure for non‐muscle invasive bladder cancer
por: Wang, Ziting, et al.
Publicado: (2022)

THE HOST RESPONSE TO CALMETTE-GUÉRIN BACILLUS INFECTION IN MICE
por: Blanden, R. V., et al.
Publicado: (1969)

Gluteal abscess: An unusual complication of Bacille Calmette-Guérin
por: Buyukoglan, Hakan, et al.
Publicado: (2011)

Bacillus Calmette-Guérin in the management of superficial bladder cancer
por: Kapoor, Rakesh, et al.
Publicado: (2008)

Bacille-Calmette-Guerin non-responders: how to manage
por: von Rundstedt, Friedrich-Carl, et al.
Publicado: (2015)

Sternal Osteomyelitis after Bacillus Calmette-Guérin Vaccination
por: Selvestravičius, Rolandas, et al.
Publicado: (2016)

Sleeping Beauty and the Story of the Bacille Calmette-Guérin Vaccine
por: Fletcher, Helen A.
Publicado: (2016)

Unraveling the Mechanism of the Antitumor Activity of Bacillus Calmette-Guérin
por: Li, Roger, et al.
Publicado: (2020)

COVID-19 and Bacillus Calmette-Guérin: What is the Link?
por: Hegarty, Paul K., et al.
Publicado: (2020)

Determinants of Bacille Calmette-Guérin scarification in Danish children
por: Jensen, Trine Mølbæk, et al.
Publicado: (2021)

Bacillus Calmette–Guérin in Immuno-Regulation of Alzheimer’s Disease
por: Klein, Benjamin Y., et al.
Publicado: (2022)

Revaccination with Bacille Calmette-Guérin: Some issues to consider
por: Datta, Manjula, et al.
Publicado: (2023)

The Recombinant Bacille Calmette–Guérin Vaccine VPM1002: Ready for Clinical Efficacy Testing
por: Nieuwenhuizen, Natalie E., et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_fv9l4qnfl2k093u6q1d5hfmi5s